Press release
Illumina Sends Letter to Shareholders Highlighting Board Strength, Weakness of Icahn's "Plan"
Illumina is led by its world-class Board members and has best-in-class governance practicesCarl Icahn's recently released "plan" demonstrates his lack of
About this update from Illumina, Inc.
[{"type":"text","content":"Illumina is led by its world-class Board members and has best-in-class governance practicesCarl Icahn's recently released \"plan\" demonstrates his lack of understanding of both Illumina and the genomics industryIllumina requests shareholders to vote the WHITE proxy card today FOR all nine of Illumina's director nomineesAnnual Meeting will be held virtually on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time)For more information, visit www.IlluminaForward.comSAN DIEGO, May 8, 2023 /PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter highlighting the strength of its Board and noting that Carl Icahn's \"plan\" for Illumina is sloppy and uninformed.\nIllumina's Board of Directors urges shareholders to protect their investment and future of the company by voting the WHITE proxy card today FOR all nine of the company's highly qualified director nominees and not for Carl Icahn's unfit three nominees. The Annual Meeting will be held on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time). Shareholders of record as of close of business on April 3, 2023, are entitled to vote at the meeting, no matter how many or how few shares they own.\nThe full text of the letter follows:\nVOTE USING THE WHITE PROXY CARD TODAY IN SUPPORT OF ILLUMINA'S NINE HIGHLY QUALIFIED DIRECTORS\nMay 8, 2023\nDear Shareholder,\nYou may have been following the news regarding Illumina's upcoming Annual Meeting and investor Carl Icahn's self-serving and deliberately misleading campaign against our company. We are writing today to remind you of our commitment to deliver value to our shareholders and the importance of voting the WHITE proxy card FOR all nine of Illumina's director nominees. Your investment in Illumina is at stake.\nCarl Icahn is attempting to replace our deeply experienced Board nominees John Thompson, Francis deSouza, CEO, and Robert Epstein, MD, with three of his unqualified nominees. Illumina's Board does not endorse Carl Icahn or his unqualified nominees and believes the election of any such nominees would detract from Illumina's core business and deprive the Board of critical leadership and perspective required for the execution of the business. Icahn's nominees bring NO additive skills, NO relevant industry experience, and NO independence fro...